Stocks
Deciphera Pharmaceuticals (DCPH) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -192.2 | -264.2 | -300.1 | -182.7 | -208.9 | -203.9 | ||
| Changes by years, y/y, % | +93% | +37% | +14% | -39% | +14% | +15.9% | |||
Deciphera Pharmaceuticals. EBITDA US GAAP, bln rub
Deciphera Pharmaceuticals. EBITDA US GAAP, changes, %
Deciphera Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Deciphera Pharmaceuticals (DCPH) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -53.3 | -52.2 | -53.7 | -50.8 | -47.3 | -203.9 | |
| Changes by years, y/y, % | +14% | +21% | +22% | +8% | -11% | |||
| Changes by quarters, q/q, % | +13% | -2% | +3% | -5% | -7% | |||
